Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TQ-B3139 |
Trade Name | |
Synonyms | TQB3139|TQ B3139|CT-711|CT 711|CT711|Envonalkib |
Drug Descriptions |
TQ-B3139 (CT-711) inhibits MET and ALK, with activity against ALK mutations, potentially resulting in decreased Alk signaling, induction of cell cycle arrest and apoptosis in tumor cells, and reduced proliferation and tumor growth (PMID: 30210922). |
DrugClasses | ALK Inhibitor 32 MET Inhibitor 59 |
CAS Registry Number | NA |
NCIT ID | C148513 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TQ-B3139 | TQ-B3139 | 10 | 0 |